duloxetine
3 clinical trials
3 abstracts
4 indications
Indication
Chronic PainIndication
Vaginal HysterectomyIndication
Postoperative PainIndication
Stress Urinary IncontinenceAbstract
Aromatase inhibitor musculoskeletal toxicity (AIMT) in patients (pts) with early breast cancer (EBC): Prevalence, management, and association with non-adherence to AI.Org: Cancer Survivorship Program, INSERM 981, Gustave Roussy, Villejuif, France, INSERM 981, Gustave Roussy Département d'Organisation du Parcours Patient, Villejuif, France, France,
Clinical trial
Pain Response Evaluation of a Combined Intervention to Cope Effectively (PRECICE)Status: Active (not recruiting), Estimated PCD: 2024-06-01
Clinical trial
Evaluating the Efficacy and Safety of Preoperative Administration of Duloxetine for Pain Management in Women Undergoing Vaginal Hysterectomy.Status: Not yet recruiting, Estimated PCD: 2024-12-31
Clinical trial
Comparisons of the Impact of Duloxetine Versus Imipramine on Therapeutic Efficacy in Women With Stress Urinary Incontinence: a Randomized Controlled Study.Status: Recruiting, Estimated PCD: 2024-12-31
Abstract
Phase III, international, multicentre, double-blind, dose increment, parallel-arm, randomised controlled trial of duloxetine versus pregabalin for opioid-unresponsive neuropathic cancer pain.Org: National Cancer Center Japan, University of Notre Dame, Flinders University, Adelaide, SA, Australia, Department of Biostatistics, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan, Japanese Organisation for Research and Treatment of Cancer (JORTC) Data Center,
Abstract
Differential efficacy of antidepressants in the treatment of hormone mediated depression in patients with ER+ breast cancer.Org: Miami Cancer Institute - Baptist Health South Florida, Baptist Health South Florida,